DERMAVANT SCIENCES GMBH
20Patents
20Active
20Granted
54Portfolio score
Filing activity: Dec 9, 2015 → Oct 20, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10195160B2 | Topical pharmaceutical compositions | Emerging Cross-Sectional Technologies | 13 | Active |
| US10376475B2 | Method of use | Human Necessities | 7 | Active |
| US10426743B2 | Topical pharmaceutical compositions | Emerging Cross-Sectional Technologies | 3 | Active |
| US10647649B2 | Process for preparing tapinarof | Chemistry; Metallurgy | 3 | Active |
| US10961175B2 | Process for preparing tapinarof | Chemistry; Metallurgy | 2 | Active |
| US11617724B2 | Topical pharmaceutical compositions | Human Necessities | 1 | Active |
| US11590088B2 | Use of Tapinarof for the treatment of chronic plaque psoriasis | Human Necessities | 1 | Active |
| US10357495B2 | Topical formulations of PDE-4 inhibitors and their methods of use | Human Necessities | 1 | Active |
| US11827605B2 | Isoquinoline compounds and their use in treating AhR imbalance | Chemistry; Metallurgy | 1 | Active |
| US11622945B2 | Topical pharmaceutical compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US12252471B2 | Isoquinoline compounds and their use in treating AhR imbalance | Chemistry; Metallurgy | 0 | Active |
| US11548853B2 | Isoquinoline compounds and their use in treating AhR imbalance | Chemistry; Metallurgy | 0 | Active |
| US10206925B2 | Topical formulations of PDE-4 inhibitors and their methods of use | Human Necessities | 0 | Active |
| US11497718B2 | Use of tapinarof for the treatment of atopic dermatitis | Human Necessities | 0 | Active |
| US11612573B2 | Topical pharmaceutical compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11458108B2 | Topical pharmaceutical compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11597692B2 | Process for preparing tapinarof | Chemistry; Metallurgy | 0 | Active |
| US12275696B2 | Process for preparing tapinarof | Chemistry; Metallurgy | 0 | Active |
| US11267788B2 | Isoquinoline compounds and their use in treating AhR imbalance | Chemistry; Metallurgy | 0 | Active |
| US11938099B2 | Use of tapinarof for the treatment of atopic dermatitis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.